Technical Analysis for NMRA - Neumora Therapeutics, Inc.

Grade Last Price % Change Price Change
F 9.38 -4.09% -0.40
NMRA closed down 4.09 percent on Monday, June 17, 2024, on 76 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Support Bullish -4.09%
Doji - Bullish? Reversal -4.09%
Upper Bollinger Band Walk Strength -4.09%
Multiple of Ten Bearish Other -4.09%
50 DMA Resistance Bearish -5.73%
20 DMA Support Bullish -5.73%
Multiple of Ten Bearish Other -5.73%
Upper Bollinger Band Touch Strength -5.73%

   Recent Intraday Alerts

Alert Time
Down 3% about 6 hours ago
Possible NR7 about 7 hours ago
Fell Below Previous Day's Low about 7 hours ago
60 Minute Opening Range Breakdown about 8 hours ago
Down 2 % about 10 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Neumora Therapeutics, Inc. Description

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Neumora’s therapeutic pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora’s work is supported by an integrated suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients suffering from brain diseases. Neumora has operations in the Greater Boston Area and South San Francisco.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Drug Development Neurodegenerative Diseases Clinical Neuroscience

Is NMRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.0
52 Week Low 8.82
Average Volume 528,143
200-Day Moving Average 0.00
50-Day Moving Average 10.19
20-Day Moving Average 9.74
10-Day Moving Average 9.93
Average True Range 0.59
RSI (14) 41.18
ADX 14.52
+DI 13.70
-DI 18.48
Chandelier Exit (Long, 3 ATRs) 8.83
Chandelier Exit (Short, 3 ATRs) 10.72
Upper Bollinger Bands 10.32
Lower Bollinger Band 9.16
Percent B (%b) 0.19
BandWidth 11.89
MACD Line -0.10
MACD Signal Line -0.14
MACD Histogram 0.0397
Fundamentals Value
Market Cap 1.43 Billion
Num Shares 153 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -9.20
Price-to-Sales 0.00
Price-to-Book 4.60
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.12
Resistance 3 (R3) 10.19 10.01 9.99
Resistance 2 (R2) 10.01 9.83 9.98 9.95
Resistance 1 (R1) 9.70 9.71 9.61 9.63 9.91
Pivot Point 9.52 9.52 9.48 9.49 9.52
Support 1 (S1) 9.21 9.34 9.12 9.14 8.85
Support 2 (S2) 9.03 9.22 9.00 8.81
Support 3 (S3) 8.72 9.03 8.77
Support 4 (S4) 8.65